Accuray Inc (ARAY)
1.49
-0.04
(-2.61%)
USD |
NASDAQ |
May 23, 16:00
1.49
0.00 (0.00%)
After-Hours: 17:18
Accuray Revenue (Annual): 447.60M for June 30, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| June 30, 2023 | 447.60M |
| June 30, 2022 | 429.91M |
| June 30, 2021 | 396.29M |
| June 30, 2020 | 382.93M |
| June 30, 2019 | 418.78M |
| June 30, 2018 | 404.90M |
| June 30, 2017 | 383.41M |
| June 30, 2016 | 398.80M |
| June 30, 2015 | 379.80M |
| June 30, 2014 | 369.42M |
| June 30, 2013 | 315.97M |
| Date | Value |
|---|---|
| June 30, 2012 | 409.22M |
| June 30, 2011 | 222.28M |
| June 30, 2010 | 221.62M |
| June 30, 2009 | 233.60M |
| June 30, 2008 | 210.38M |
| June 30, 2007 | 140.45M |
| June 30, 2006 | 52.90M |
| June 30, 2005 | 22.38M |
| June 30, 2004 | 19.57M |
| June 30, 2003 | 2.71M |
| June 30, 2002 | 19.35M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
382.93M
Minimum
2020
447.60M
Maximum
2023
415.10M
Average
418.78M
Median
2019
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| Integer Holdings Corp | 1.597B |
| ResMed Inc | 4.223B |
| Glaukos Corp | 314.71M |
| Perspective Therapeutics Inc | -- |